The cancer epidemiology group focuses on three principal research lines:
(1) the assessment of the long‑term risks of second malignancy and cardiovascular disease following treatment of (non)Hodgkin lymphoma, breast cancer, testicular cancer and childhood malignancy.
(2) A topic related to late effects of cancer treatment concerns our research related to breast implants. In 2008 we reported the first epidemiological study demonstrating that breast implants are associated with a strongly increased risk of a rare type of breast lymphoma, i.e. anaplastic large-cell lymphoma (ALCL).
(3) the assessment of the roles of and hormone-related and genetic risk factors in the etiology of breast and ovarian cancer; Special interest is in late effects of ovarian stimulation for In Vitro Fertilization and cancer etiology in BRCA1/2 families.
Epidemiologic methods are combined with molecular analyses to examine gene-environment and gene-treatment interactions.